They should sell off the
They should sell off the diagnostics business, especially the DxN program. Dick Creag*r isn't going to be able to launch this year, and won't be able to launch till at least 2nd quarter next year. (And...
View ArticleDXH 800 Flow Cell issues
What's the deal? Replacing the flow cell every 2 weeks to fix Diff problem. Any word on what the REAL problem is????
View ArticleJust because GL deserves 6000
Just because GL deserves 6000 posts before he rides off into the sunset next year.
View ArticleAdd Bayer and Siemens to your
Add Bayer and Siemens to your list of the worst. One has to wonder if it's the companies or the industry. Diagnostics is no longer the growth business it was. New analyzers have very little that's new...
View ArticleOn the supply side, medicine
On the supply side, medicine will become a far less attractive career for talented young people. More doctors will restrict practice or retire early rather than accept lower incomes and work conditions...
View ArticleHow can Biofind continue to
How can Biofind continue to allow people to get anonymously career assassinated? Someone did the same thing to me when I worked for a company in Massachusetts
View ArticleAlready, many practices are
Already, many practices are closed to Medicaid recipients, some also to Medicare. Perhaps one solution would be a contract. Since something like 85-90% of residencies are funded by Medicaid/Medicare,...
View ArticleThey are all dead .. mentally
They are all dead .. mentally and emotionally. Perhaps the term 'suspended animation' would be appropriate for Siemens DX patients....I mean employees.
View ArticleGetting back to the topic,
Getting back to the topic, again, CTI is proving, frankly, unproductive. At ground level, its a constant industry-academia tug-of-war. There is nothing flawed in the concept. It is simply that on our...
View Articlethis all sounds like J&J is
this all sounds like J&J is playing one suitor against another all in a bid to wring as high a price as possible. A logical play by J&J. J&J (remember their Credo?) has spent billions...
View ArticleOne does not need to buy OCD
One does not need to buy OCD to obtain rights to certain infectious disease tests. J&J has licensed these tests to others in the past and there is no obvious reason they wouldn't continue to do so....
View ArticleSame procedure as every year
Same procedure as every year at Q. LAY OFFS ??? AND NEW SHARES FOR P.S. and R.S. ONLY ??? DJ DGAP-CMS: QIAGEN N.V.: Release of a capital market information 17.12.13 18:14 Dow Jones Newswires DJ...
View ArticleGL is a failed CEO. But one
GL is a failed CEO. But one thing he did learn from me while going through his MBA program. That is if you can beat them, sell.! In that sense, he unlocked shareholder value. But at the cost of many...
View ArticleDxC..... Dogs and
DxC..... Dogs and Cats.....? Analyser. Dogs multiplied by Cats..... Oh fuck 2016 my life ends
View Article"Add to that the paucity of
"Add to that the paucity of new tests that need to be developed and you wind up with a static business..." Is there no need for research to develop new tests to diagnose Alzheimer's Disease, cancer,...
View Article